News And Announcements
Mike Ashley lambasts Sports Direct investors over 'backstabbing'
Sports Direct founder and chief executive Mike Ashley has accused shareholders of “stabbing him in the back” and of “hounding” former chairman Keith Hellawell out of his job.
Hydro withdraws offer for Rio Tinto's aluminium assets
Rio Tinto said on Friday that Norway's Hydro has withdrawn its offer for the miner's aluminium assets.
Centrica appoints former BP bigwig to board
Multinational energy and services company Centrica on Friday appointed Richard Hookway to its board as chief executive of Centrica Business from 1 December.
JD Wetherspoon to nudge up prices as costs rise
JD Wetherspoon reported solid annual results and boss Tim Martin took time out of his traditional pro-Brexit diatribe to say that 4. 0% growth would be needed in the present year to maintain profits.
Tarsus raising £24m to fund two acquisitions and a partnership
Business-to-business media company Tarsus Group has agreed to two acquisitions and a strategic partnership, it announced on Friday.
Management Resource Solutions subsidiary wins Aussie federal contract
Management Resource Solutions announced on Friday that its subsidiary Bachmann Plant Hire (BPH) has secured a AUD 2. 0m contract providing civil and earthworks on an Australian Federal Government project in the Northern Territory of Australia.
Nationwide to pour another £1.3bn into technology
Nationwide Building Society announced on Friday that it is making an additional technology investment of £1. 3bn, taking its overall investment plans to £4. 1bn over the next five years.
Block Commodities teams up with Pure Grow Africa for Uganda project
Commodity trader Block Commodities announced a strategic partnership with Pure Grow Africa - a supplier of agricultural produce based in Uganda - on Friday.
British Steel says 400 job cuts 'unavoidable'
British Steel could cut up to 10% of its workforce as part of a turnaround plan as the business looks to try and keep up with the changes in the industry including the rising costs that come with a weaker pound.
Shire gains as takeover approved by China
Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.
Investec puts in robust performance amid South Africa, Brexit uncertainty
Investec updated the market on its core business performance for the first half of its financial year ahead of its close period on Friday, reporting that the company had continued to see macro challenges in its key operating geographies.
Investec Asset Management to be spun out as separately listed company
Investec announced the demerger and listing of Investec Asset Management on Friday, following a strategic review process carried out by its board and executive directors.
GSK's ViiV seeks approval for new one-tablet HIV-1 treatment
ViiV Healthcare - the HIV specialist majority-owned by GlaxoSmithKline, alongside minority shareholders Pfizer and Shionogi - announced the submission of a marketing authorisation application to the European Medicines Agency on Friday, for a single-tablet, two-drug regimen of dolutegravir and lamivudine for the treatment of the HIV-1 infection.
Boardroom veteran Martin Read to chair merged SSE-npower entity
SSE and npower parent innogy have appointed Dr Martin Read CBE as chairman-designate for the new independent British energy supply and services company they have agreed to form, the announced on Friday, subject to final regulatory approval.
Sirius Minerals secures royalty deal with Hancock
Sirius Minerals said on Friday that it has secured a new $250m funding deal that should give it sufficient funding to the second quarter of 2019.
Bank of Georgia wins consumer bank award for second year
Bank of Georgia Group announced on Friday that its banking subsidiary JSC Bank of Georgia has been awarded a ‘Consumer Digital Bank of Distinction Award’ from Global Finance in Central and Eastern Europe, for the second consecutive year.
AstraZeneca's Lumoxiti gets FDA approval as hairy cell leukaemia treatment
AstraZeneca and its global biologics research and development arm MedImmune announced on Friday that the US Food and Drug Administration (FDA) has approved Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukaemia.
Close Brothers to sell retail point of sale finance business to Klarna
Close Brothers has announced the sale of its retail point of sale finance business, Close Brothers Retail Finance, to Swedish payment solutions group Klarna for an undisclosed sum.